Clinical Trials Sponsored by Bionorte

Total 16 results

BioPorto Diagnostics

Completed

NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care

Acute Kidney Injury

United States
BioPorto Diagnostics

Unknown

The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population

Kidney Injury

United States
Bionode, LLC

Unknown

Clinical Study Of The Bionode System In Subjects With Elevated IOP

Unmedicated IOP Before and After Treatment

Canada
Bionorte
University of the Basque Country (UPV/EHU); Osakidetza

Completed

Quality of Cardiopulmonary Resuscitation Guided by AED vs Telephone-assistance (QRCP)

Cardiopulmonary Resuscitation

Spain
BioCorteX Inc
Tempus AI

Recruiting

Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.

Breast Cancer

United States
Bionor Immuno AS

Completed

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

HIV I Infection

Germany, United States, Spain, United Kingdom, Italy
Bionor Immuno AS

Completed

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

HIV-1 Infection

Norway
Bionorte
University of the Basque Country (UPV/EHU); Osakidetza

Completed

Ethyl Chloride Vapocoolant as Anesthesia for Arterial Punctures

Pain | Anesthesia

Spain
Bionor Immuno AS

Completed

Re-boosting of HIV-1 Infected Subjects With Vacc-4x (Re-boost)

HIV-1 Infection

United States, Spain, Germany, Italy, United Kingdom
Hillerod Hospital, Denmark
BioPorto Diagnostics

Active, not recruiting

Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease

Chronic Kidney Diseases | AKI | Acute Kidney Injury | CKD | Emergency Department | NGAL | Neutrophil Gelatinase-associated Lipocalin

Denmark
Children's Hospital Medical Center, Cincinnati
BioPorto Diagnostics

Completed

Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications (NINJA NGAL)

Acute Kidney Injury | Nephrotoxicity

United States
Bionor Immuno AS
Celgene Corporation

Completed

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (IMID)

HIV-1 Infection

Germany
Bionor Immuno AS
Celgene Corporation

Completed

Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir (REDUC)

HIV I Infection

Denmark
Hellenic Institute for the Study of Sepsis
The BioArte

Completed

NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification (BIOARTE)

Pneumonia | Bacteremia | Acute Pyelonephritis | Biliary Tract Infection

Greece
Oslo University Hospital
Eurocine Vaccines AB; Bionor Immuno AS

Completed

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

HIV Infection

Norway
University of Copenhagen
Arla Foods; Hoeng Fonden; Bionor Pharma

Unknown

Effect of UHT Treated Milk on Blolipid Profile (UHT)

To Investigate the Effect of UHT Treated Milk Versus Pasteurised Milk on Bloodlipid Profil

Denmark

Clinical Trials Sponsored by Bionorte

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations